OptiNose
OPTN
OPTN was delisted on the 20th of May, 2025.
40 hedge funds and large institutions have $48.7M invested in OptiNose in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 23 reducing their positions, and 28 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
0.03% more ownership
Funds ownership: 4.81% → 4.84% (+0.03%)
33% less capital invested
Capital invested by funds: $72.7M → $48.7M (-$24M)
38% less funds holding
Funds holding: 65 → 40 (-25)
65% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 23
86% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 28
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$2.86M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$1.84M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.36M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$366K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$255K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$4.29M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$2.06M |
| 3 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
-$1.44M |
| 4 |
EIP
Easterly Investment Partners
Beverly,
Massachusetts
|
-$974K |
| 5 |
JGC
J. Goldman & Co
New York
|
-$452K |
OPTN Hedge Fund Activity: Q4 2024 in Review
40 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in OptiNose (OPTN) for Q4 2024, worth a combined $48.7M — down 33% from $72.7M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of OPTN and 4 opened new positions — a net loss of 24 holders — while 23 trimmed existing stakes and 8 added.
The largest buyer was Rosalind Advisors, adding an estimated $2.86M. The largest seller was Great Point Partners, cutting an estimated $4.29M.
- 40 institutional investors held OptiNose (OPTN) as of Q4 2024, down from 65 in Q3 2024.
- Funds reported $48.7M of OptiNose stock for Q4 2024, down 33% quarter-over-quarter.
- 4 funds opened new OptiNose positions in Q4 2024 and 28 closed out, a net change of -24 holders.
- The largest OptiNose buyer in Q4 2024 was Rosalind Advisors, an estimated $2.86M added.
- The largest OptiNose seller in Q4 2024 was Great Point Partners, an estimated $4.29M sold.
Based on aggregated 13F filings for Q4 2024.